Genic Co. Ltd Cash Flow-to-Debt Ratio
Genic Co. Ltd cash flow-to-debt ratio. Genic Co. Ltd (123330) has a Cash Flow-to-Debt Ratio of -0.04x as of June 2026, meaning its operating cash flow of ₩-1.43 Billion could theoretically repay 0% of its total liabilities (₩35.13 Billion) in one year. Check 123330 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Genic Co. Ltd (2012–2025)
Cash flow-to-debt ratio of Genic Co. Ltd from 2012 to 2025. Historical debt coverage capacity for Genic Co. Ltd across 14 annual periods. Check 123330 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Genic Co. Ltd Cash Flow-to-Debt Ratio by Year (2012–2025)
Genic Co. Ltd cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Genic Co. Ltd. For the full cash flow conversion analysis, see 123330 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | ₩20.65 Billion | ₩15.49 Billion | ▲ +7732.4% |
| 2024 | 0.02x | ₩272.46 Million | ₩16.00 Billion | ▲ +175.3% |
| 2023 | -0.02x | ₩-268.31 Million | ₩11.87 Billion | ▼ -283.1% |
| 2022 | 0.01x | ₩177.94 Million | ₩14.41 Billion | ▼ -90.3% |
| 2021 | 0.13x | ₩3.32 Billion | ₩26.11 Billion | ▲ +1561.8% |
| 2020 | 0.01x | ₩212.66 Million | ₩27.77 Billion | ▼ -82.8% |
| 2019 | 0.04x | ₩1.38 Billion | ₩31.01 Billion | ▲ +117.1% |
| 2018 | -0.26x | ₩-8.90 Billion | ₩34.37 Billion | ▼ -147.9% |
| 2017 | -0.10x | ₩-4.09 Billion | ₩39.11 Billion | ▼ -315.1% |
| 2016 | 0.05x | ₩1.93 Billion | ₩39.63 Billion | ▼ -61.2% |
| 2015 | 0.13x | ₩3.63 Billion | ₩28.97 Billion | ▼ -56.1% |
| 2014 | 0.29x | ₩5.80 Billion | ₩20.34 Billion | ▼ -9.2% |
| 2013 | 0.31x | ₩3.68 Billion | ₩11.70 Billion | ▼ -47.5% |
| 2012 | 0.60x | ₩4.31 Billion | ₩7.20 Billion | — |